As of June 2024 Arcturus Therapeutics has a market cap of $1.04 Billion. This makes Arcturus Therapeutics the world's 5105th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.04 B | 24.05% |
2023 | $0.84 B | 87.08% |
2022 | $0.45 B | -53.84% |
2021 | $0.97 B | -8.18% |
2020 | $1.06 B | 545.71% |
2019 | $0.16 B | 238.91% |
2018 | $48.55 M | -42.22% |
2017 | $84.02 M | 45.17% |
2016 | $57.87 M | -66.56% |
2015 | $0.17 B | 238.64% |
2014 | $51.11 M | -79.18% |
2013 | $0.24 B |
On May 31st, 2024 the market cap of Arcturus Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | -98.25% | Bahamas |
NRC Health
NRC | $0.67 B | -35.85% | ๐บ๐ธ USA |